John Paulson‘s hedge fund has increased its holdings in Mylan NV to 4.5%. The fund, which supports Teva Pharmaceutical Industries Ltd.’s (NYSE: TEVA; TASE: TEVA) takeover bid for Mylan, bought seven million Mylan shares on April 30, giving it a total of 22 million shares.
Mylan is now Paulson’s second largest holding, with a value of $1.6 billion.
Please help us out :
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at [email protected].
Thank you.
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at [email protected].
Thank you.
The purchase will give Paulson greater influence on the Mylan shareholders and board of directors, after company management rejected Teva’s offer to purchase, preferring meanwhile to continue its attempts at promoting a merger with Perrigo Company (NYSE:PRGO; TASE:PRGO)…. [READ MORE]
Published by Globes [online], Israel business news – www.globes-online.com
